What is the ticker symbol for Arrowhead Pharmaceuticals, Inc.?

The ticker symbol for Arrowhead Pharmaceuticals, Inc. is NASDAQ:ARWR

Does Arrowhead Pharmaceuticals, Inc. pay dividends?

No, Arrowhead Pharmaceuticals, Inc. does not pay dividends

What sector is Arrowhead Pharmaceuticals, Inc. in?

Arrowhead Pharmaceuticals, Inc. is in the Healthcare sector

What industry is Arrowhead Pharmaceuticals, Inc. in?

Arrowhead Pharmaceuticals, Inc. is in the Biotechnology industry

What country is Arrowhead Pharmaceuticals, Inc. based in?

Arrowhead Pharmaceuticals, Inc. is headquartered in United States

When did Arrowhead Pharmaceuticals, Inc. go public?

Arrowhead Pharmaceuticals, Inc. initial public offering (IPO) was on December 16, 1993

Is Arrowhead Pharmaceuticals, Inc. in the S&P 500?

No, Arrowhead Pharmaceuticals, Inc. is not included in the S&P 500 index

Is Arrowhead Pharmaceuticals, Inc. in the NASDAQ 100?

No, Arrowhead Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

Is Arrowhead Pharmaceuticals, Inc. in the Dow Jones?

No, Arrowhead Pharmaceuticals, Inc. is not included in the Dow Jones index

When was Arrowhead Pharmaceuticals, Inc. last earnings report?

Arrowhead Pharmaceuticals, Inc.'s most recent earnings report was on August 4, 2026

When does Arrowhead Pharmaceuticals, Inc. report earnings?

The next expected earnings date for Arrowhead Pharmaceuticals, Inc. is November 24, 2026

ARWR Stock Financials, Chart, Sentiment & Profile

Summary

Current Price: As of today, ARWR price is $66.48, down -1.86% on September 18, 2026
Current Price All-Time High: ARWR price is currently -97.73% below its historical high of $2,925.00 set on December 16, 1993
Market Cap: ARWR current market cap is $9B, up +115.12% over the past 365 days
Revenue: ARWR current annual revenue is $829.45M, up +23258.15% year-over-year
Next Earnings: The next earnings release for ARWR is on November 24, 2026

Profile

Company profile for Arrowhead Pharmaceuticals, Inc. (ARWR)
Metric	Value
Full Name	Arrowhead Pharmaceuticals, Inc.
Ticker	NASDAQ: ARWR
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology
Country	United States
IPO	Dec 16, 1993
Indexes	Not included
Website	arrowheadpharma.com
Employees	609

Key Metrics

Arrowhead Pharmaceuticals, Inc. Key Details
Metric	Value	Date
Price	$66.48	Sep 18, 26
Price, 1D Change	-1.86%	Sep 18, 26
Market Cap	$9B	Sep 18, 26
	-	Sep 18, 26
PE Ratio	-	Sep 18, 26
Beta	1.61	Sep 18, 26
Revenue	$829.45M	Sep 30, 25
Revenue, 1Y Change	+23,258.15%	Sep 30, 25
EPS	-$0.01	Sep 30, 25
EPS, 1Y Change	+99.76%	Sep 30, 25

Events

Arrowhead Pharmaceuticals, Inc. Events
Metric	Value	Date
Next Earnings		Nov 24, 26
Last Qtr. Earnings		Aug 4, 26
Last Ann. Earnings		Nov 25, 25
Last Ex-Dividend	N/A	N/A
Next Ex-Dividend	N/A	N/A
Last Split	1:10	Nov 17, 11
Next Split	N/A	N/A
Last Ticker Change	N/A	N/A
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

ARWR Estimates
Metric	Value	Date
EPS	-$0.01	Sep 30, 25
EPS Estimate	-$3.54	Nov 24, 26
EPS Est. Change	-28,910.66%	Nov 24, 26
Revenue	$829.45M	Sep 30, 25
Revenue Estimate	$461.20M	Nov 24, 26
Revenue Est. Change	-44.40%	Nov 24, 26
Current Price	$66.48	Sep 18, 26
Price Target	$106.00	-
Price Tgt. Change	+59.45%	-

🔒 Log In To Unlock Full Data

EPS

ARWR EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2024	-$4.53	-$5.00	-10.53%
2025	-$0.03	-$0.01	+63.69%
2026	-$3.54	N/A	-28,910.66%
2027	-$4.80	N/A	-39,284.43%

Revenue

ARWR revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2024	$61.60M	$3.55M	-94.24%
2025	$757.44M	$829.45M	+9.51%
2026	$461.20M	N/A	-44.40%
2027	$339.94M	N/A	-59.02%

🔒 Log In To Unlock Full Data

Performance

ARWR Performance
Metric	Value	Date
Price, 1Y	+110.98%	Sep 18, 26
Price, 3Y	+136.33%	Sep 18, 26
Market Cap, 1Y	+115.12%	Sep 18, 26
Market Cap, 3Y	+210.82%	Sep 18, 26
Revenue, 1Y	+23,258.15%	Sep 30, 25
Revenue, 3Y	+241.01%	Sep 30, 25
EPS, 1Y	+99.76%	Sep 30, 25
EPS, 3Y	+99.27%	Sep 30, 25

🔒 Log In To Unlock Full Data

Technicals

ARWR Technical Indicators
Metric	Value	Date
Current Price	$66.48	Sep 18, 26
SMA 200	$72.48	Sep 18, 26
SMA 50	$82.73	Sep 18, 26
EMA 200	$69.85	Sep 18, 26
EMA 50	$81.29	Sep 18, 26
MACD	-$4.26	Sep 18, 26
Beta	1.61	Sep 18, 26
ATR	$4.04	Sep 18, 26
14-Day RSI	25.20	Sep 18, 26
10-Day Volatility	68.66%	Sep 18, 26

Dividends

ARWR Dividends
Metric	Value	Date
	-	N/A
Upcoming	N/A	N/A
	-	Sep 18, 26
	-	Sep 30, 25
	$0.00	Sep 30, 25
	0.00%	Sep 30, 25

🔒 Log In To Unlock Full Data

Income & Profitability

ARWR Income & Profitability
Metric	Value	Date
Revenue	$829.45M	Sep 30, 25
EPS	-$0.01	Sep 30, 25
Gross Profit	$805.52M	Sep 30, 25
Gross Margin	97.12%	Sep 30, 25
Operating Income	$98.35M	Sep 30, 25
Operating Margin	11.86%	Sep 30, 25
Net Income	$30.11M	Sep 30, 25
Net Margin	3.63%	Sep 30, 25
EBITDA	$122.27M	Sep 30, 25

🔒 Log In To Unlock Full Data

Financial Health

ARWR Financial Health
Metric	Value	Date
Debt To Equity	1.57	Sep 30, 25
	4.86	Sep 30, 25
	4.86	Sep 30, 25
	-	Sep 30, 25
	3	Jun 30, 26
	5.78	Sep 18, 26

Valuations

ARWR Valuations
Metric	Value	Date
PE Ratio	-	Sep 18, 26
	13.99	Sep 18, 26
	20.12	Sep 18, 26
	-45.55	Sep 18, 26
	-	N/A

Balance Sheet

ARWR Balance Sheet
Metric	Value	Date
Book Value	$466.05M	Sep 30, 25
	$919.37M	Sep 30, 25
	$1.45B	Sep 30, 25
	$950.64M	Sep 30, 25
	$947.02M	Sep 30, 25
	$195.49M	Sep 30, 25
Total Debt	$733.68M	Sep 30, 25
	$47.29M	Sep 30, 25
	$17.67M	Sep 30, 25

Expenses

ARWR Expenses
Metric	Value	Date
	$831.08M	Sep 30, 25
	$707.17M	Sep 30, 25
	$23.93M	Sep 30, 25
	$0.00	Sep 30, 25
	$23.93M	Sep 30, 25
	$0.00	Sep 30, 25
	$21.42M	Sep 30, 25

Cash Flow

ARWR Cash Flow
Metric	Value	Date
	$179.55M	Sep 30, 25
	-$129.29M	Sep 30, 25
	$74.01M	Sep 30, 25
Capex	$22.67M	Sep 30, 25
	$156.89M	Sep 30, 25

Recent analyst updates

ARWR Recent analyst updates
Metric	Value	Date
Citigroup		Sep 8, 26
HC Wainwright & Co.	→	Sep 1, 26
RBC Capital	→	Aug 31, 26
Chardan Capital	→	Aug 31, 26
HC Wainwright & Co.	→	Aug 6, 26
B. Riley Securities	→	Jul 30, 26
HC Wainwright & Co.	→	Jul 27, 26
Piper Sandler	→	Jul 23, 26
Morgan Stanley	→	Jul 23, 26
Chardan Capital	→	Jul 22, 26

Analyst sentiment

Institutional ownership

No data

Screeners with ARWR

FAQ

What is the ticker symbol for Arrowhead Pharmaceuticals, Inc.?: The ticker symbol for Arrowhead Pharmaceuticals, Inc. is NASDAQ:ARWR
Does Arrowhead Pharmaceuticals, Inc. pay dividends?: No, Arrowhead Pharmaceuticals, Inc. does not pay dividends
What sector is Arrowhead Pharmaceuticals, Inc. in?: Arrowhead Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Arrowhead Pharmaceuticals, Inc. in?: Arrowhead Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Arrowhead Pharmaceuticals, Inc. based in?: Arrowhead Pharmaceuticals, Inc. is headquartered in United States
When did Arrowhead Pharmaceuticals, Inc. go public?: Arrowhead Pharmaceuticals, Inc. initial public offering (IPO) was on December 16, 1993
Is Arrowhead Pharmaceuticals, Inc. in the S&P 500?: No, Arrowhead Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Arrowhead Pharmaceuticals, Inc. in the NASDAQ 100?: No, Arrowhead Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Arrowhead Pharmaceuticals, Inc. in the Dow Jones?: No, Arrowhead Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Arrowhead Pharmaceuticals, Inc. last earnings report?: Arrowhead Pharmaceuticals, Inc.'s most recent earnings report was on August 4, 2026
When does Arrowhead Pharmaceuticals, Inc. report earnings?: The next expected earnings date for Arrowhead Pharmaceuticals, Inc. is November 24, 2026

Data Sources & References

ARWR Official Website arrowheadpharma.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/879407/000087940725000029/0000879407-25-000029-index.htm
ARWR Profile on Yahoo Finance finance.yahoo.com/quote/ARWR
ARWR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arwr